Bicycle Therapeutics appoints Rolf H. Günther, MD, PhD as CEO

Cambridge, UK. Bicycle Therapeutics, a next generation biotherapeutics company co-founded by Sir Gregory Winter and Professor Christian Heinis, today announced the appointment of Rolf Günther, MD, PhD as Chief Executive Officer. Bicycle Therapeutics has developed a proprietary bicyclic peptide technology that enables the discovery of a new class of drug candidates with antibody-like selectivity and specificity that can be manufactured with economics similar to new chemical entities. Under Dr Günther’s leadership, the company will apply the technology to drug discovery projects addressing a wide range of challenging targets, through its own programmes and by entering into corporate partnerships. Read More